InvestorsHub Logo
Followers 32
Posts 5818
Boards Moderated 0
Alias Born 05/23/2006

Re: vinmantoo post# 331747

Tuesday, 09/17/2019 10:14:44 AM

Tuesday, September 17, 2019 10:14:44 AM

Post# of 345969
tell that to USCF... and Merck

http://cancer.ucsf.edu/gi/clinical-trials

CC#194514: A Phase 2 Multicenter, Open-Label, Non-Randomized Study of Bavituximab Plus Pembrolizumab in Patients with Advanced Gastric or Gastroesophageal Cancer Who Have Progressed On or After At Least One Prior Standard Therapy
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News